437 results on '"Sahin, Ozgur"'
Search Results
2. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer
3. Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer
4. Continuously tracked, stable, large excursion trajectories of dipolar coupled nuclear spins
5. A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer
6. High-Field Magnetometry with Hyperpolarized Nuclear Spins
7. Alterations of ceramide synthesis induce PD-L1 internalization and signaling to regulate tumor metastasis and immunotherapy response
8. High field magnetometry with hyperpolarized nuclear spins
9. Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization
10. Hydration solids
11. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
12. High Resolution Dielectric Characterization of Single Cells and Microparticles Using Integrated Microfluidic Microwave Sensors
13. Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer
14. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis
15. Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
16. HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin
17. EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers
18. TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice
19. Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies
20. Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
21. TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness
22. Abstract A008: Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer
23. Flexible Nanopipettes for Minimally Invasive Intracellular Electrophysiology In Vivo
24. Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer
25. Time-varying tip-sample force measurements confirm steady-state dynamics in tapping-mode atomic force microscopy
26. Harnessing bifurcations in tapping-mode atomic force microscopy to calibrate time-varying tip-sample force measurements
27. Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
28. Cellular nanoscale stiffness patterns governed by intracellular forces
29. Large and reversible myosin-dependent forces in rigidity sensing
30. Cholesterol biogenesis is a PTEN‐dependent actionable node for the treatment of endocrine therapy‐refractory cancers
31. Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer
32. Research on perinatal Cytomegalovirusinfections: Bibliometric Analysis (1990–2022)
33. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
34. Can Stria Gravidarum Predict Surgical Fluid Loss in Cesarean Section?
35. A novel prenatal index predicting the probability of neonatal intensive care in pregnants: amnion progesterone receptor to alfa fetoprotein rate
36. TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness.
37. Abstract 5728: Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification
38. Abstract 3883: Overcoming tamoxifen resistance by re-activating cAMP-Ca2+−ROS-ferroptosis axis in ER+ breast cancer
39. Abstract 578: Novel bi-thiazole LOX inhibitors to overcome chemotherapy resistance in triple negative breast cancer
40. Figure S1 from A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate
41. Supplementary Tables from A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate
42. Supplementary Data from A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate
43. Table S2 from Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors
44. Supplementary Figures from Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
45. Figure S1-11 from Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors
46. Supplementary Table from Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
47. Data from Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
48. Data from 14-3-3ζ Orchestrates Mammary Tumor Onset and Progression via miR-221–Mediated Cell Proliferation
49. Supplementary Figure 2 from Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
50. Supplementary Figure 7 from Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.